Kambiz Varmira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kambiz Varmira has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Habibi
Faculty of Chemical and Petroleum Engineering, Razi University, Kermanshah, Iran
5 shared publications - Hojat Veisi
Department of Chemistry, Payame Noor University, Tehran, Iran
4 shared publications - Mona Hamelian
Research Center of Oils and Fats, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 shared publications - Seyed Jalal Hosseinimehr
Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
3 shared publications Seyed Mohammad Abedi
3 shared publications- Ali Reza Jalalvand
Kermanshah Univ Med Sci, Hlth Inst, Pharmaceut Sci Res Ctr, Kermanshah, Iran
2 shared publications
Latest Publications
- Open Access
- 16 April 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1
Author Correction: Comparison of the differentiation of ovine fetal bone-marrow mesenchymal stem cells towards osteocytes on chitosan/alginate/CuO-NPs and chitosan/alginate/FeO-NPs scaffolds
- 16 April 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1
Open AccessAuthor Correction: Comparison of the differentiation of ovine fetal bone-marrow mesenchymal stem cells towards osteocytes on chitosan/alginate/CuO-NPs and chitosan/alginate/FeO-NPs scaffolds
- Open Access
- 2 January 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-23
Comparison of the differentiation of ovine fetal bone-marrow mesenchymal stem cells towards osteocytes on chitosan/alginate/CuO-NPs and chitosan/alginate/FeO-NPs scaffolds
In the current study, the creation of a chitosan/alginate scaffold hydrogel with and without FeO-NPs or CuO-NPs was studied. From fetal ovine bone marrow mesenchymal stem cells (BM-MSCs) were isolated and cultivated. Their differentiation into osteocyte and adipose cells was investigated. Also, on the scaffolds, cytotoxicity and apoptosis were studied. To investigate the differentiation, treatment groups include: (1) BM-MSCs were plated in DMEM culture medium with high glucose containing 10% FBS and antibiotics (negative control); (2) BM-MSCs were plated in osteogenic differentiation medium (positive control); (3) positive control group + FeO-NPs, (4) positive control group + CuO-NPs; (5) BM-MSCs were plated in osteogenic differentiation medium on chitosan/alginate scaffold; (6) BM-MSCs were plated in osteogenic differentiation medium on chitosan/alginate/FeO-NPs scaffold; and (7) BM-MSCs were plated in osteogenic differentiation medium on chitosan/alginate/CuO-NPs scaffold. Alkaline phosphatase enzyme concentrations, mineralization rate using a calcium kit, and mineralization measurement by alizarin staining quantification were evaluated after 21 days of culture. In addition, qRT-PCR was used to assess the expression of the ALP, ColA, and Runx2 genes. When compared to other treatment groups, the addition of CuO-NPs in the chitosan/alginate hydrogel significantly increased the expression of the ColA and Runx2 genes (p < 0.05). However, there was no significant difference between the chitosan/alginate hydrogel groups containing FeO-NPs and CuO-NPs in the expression of the ALP gene. It appears that the addition of nanoparticles, in particular CuO-NPs, has made the chitosan/alginate scaffold more effective in supporting osteocyte differentiation.
- 2 January 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-23
Open AccessComparison of the differentiation of ovine fetal bone-marrow mesenchymal stem cells towards osteocytes on chitosan/alginate/CuO-NPs and chitosan/alginate/FeO-NPs scaffolds
In the current study, the creation of a chitosan/alginate scaffold hydrogel with and without FeO-NPs or CuO-NPs was studied. From fetal ovine bone marrow mesenchymal stem cells (BM-MSCs) were isolated and cultivated. Their differentiation into osteocyte and adipose cells was investigated. Also, on the scaffolds, cytotoxicity and apoptosis were studied. To investigate the differentiation, treatment groups include: (1) BM-MSCs were plated in DMEM culture medium with high glucose containing 10% FBS and antibiotics (negative control); (2) BM-MSCs were plated in osteogenic differentiation medium (positive control); (3) positive control group + FeO-NPs, (4) positive control group + CuO-NPs; (5) BM-MSCs were plated in osteogenic differentiation medium on chitosan/alginate scaffold; (6) BM-MSCs were plated in osteogenic differentiation medium on chitosan/alginate/FeO-NPs scaffold; and (7) BM-MSCs were plated in osteogenic differentiation medium on chitosan/alginate/CuO-NPs scaffold. Alkaline phosphatase enzyme concentrations, mineralization rate using a calcium kit, and mineralization measurement by alizarin staining quantification were evaluated after 21 days of culture. In addition, qRT-PCR was used to assess the expression of the ALP, ColA, and Runx2 genes. When compared to other treatment groups, the addition of CuO-NPs in the chitosan/alginate hydrogel significantly increased the expression of the ColA and Runx2 genes (p < 0.05). However, there was no significant difference between the chitosan/alginate hydrogel groups containing FeO-NPs and CuO-NPs in the expression of the ALP gene. It appears that the addition of nanoparticles, in particular CuO-NPs, has made the chitosan/alginate scaffold more effective in supporting osteocyte differentiation.
- 27 September 2022
- Published by Springer Nature in Catalysis Letters
- Vol. 153 (8) , 2341-2351
Catalytic Reduction of 4-Nitrophenol Using Green Synthesized Silver and Gold Nanoparticles over Thyme Plant Extract
- 27 September 2022
- Published by Springer Nature in Catalysis Letters
- Vol. 153 (8) , 2341-2351
Catalytic Reduction of 4-Nitrophenol Using Green Synthesized Silver and Gold Nanoparticles over Thyme Plant Extract
- 6 April 2021
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 18 (5) , 1842-1861
MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy
Mucin 1 (MUC1) is a large, transmembrane mucin glycoprotein overexpressed in most adenocarcinomas and plays an important role in tumor progression. Regarding its cellular distribution, biochemical features, and function, tumor-related MUC1 varies from the MUC1 expressed in normal cells. Therefore, targeting MUC1 for cancer immunotherapy and imaging can exploit the difference between cancerous and normal cells. Radiopharmaceuticals have a potential use as carriers for the delivery of radionuclides to tumors for a diagnostic imaging and radiotherapy. Several radiolabeled targeting molecules like peptides, antibodies, and aptamers have been efficiently demonstrated in detecting and treating cancer by targeting MUC1. This review provides a brief overview of the current status of developments and applications of MUC1-targeted radiopharmaceuticals in cancer imaging and therapy.
- 6 April 2021
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 18 (5) , 1842-1861
MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy
Mucin 1 (MUC1) is a large, transmembrane mucin glycoprotein overexpressed in most adenocarcinomas and plays an important role in tumor progression. Regarding its cellular distribution, biochemical features, and function, tumor-related MUC1 varies from the MUC1 expressed in normal cells. Therefore, targeting MUC1 for cancer immunotherapy and imaging can exploit the difference between cancerous and normal cells. Radiopharmaceuticals have a potential use as carriers for the delivery of radionuclides to tumors for a diagnostic imaging and radiotherapy. Several radiolabeled targeting molecules like peptides, antibodies, and aptamers have been efficiently demonstrated in detecting and treating cancer by targeting MUC1. This review provides a brief overview of the current status of developments and applications of MUC1-targeted radiopharmaceuticals in cancer imaging and therapy.
- 1 December 2018
- Published by Elsevier in Journal of the Taiwan Institute of Chemical Engineers
- Vol. 93, 21-30
Green synthesis, antibacterial, antioxidant and cytotoxic effect of gold nanoparticles using Pistacia Atlantica extract
- 1 December 2018
- Published by Elsevier in Journal of the Taiwan Institute of Chemical Engineers
- Vol. 93, 21-30
Green synthesis, antibacterial, antioxidant and cytotoxic effect of gold nanoparticles using Pistacia Atlantica extract
- 1 November 2018
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 119, 838-848
Nontoxic silver nanocluster-induced folding, fibrillation, and aggregation of blood plasma proteins
- 1 November 2018
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 119, 838-848
Nontoxic silver nanocluster-induced folding, fibrillation, and aggregation of blood plasma proteins
- 6 August 2018
- Published by Springer Nature in Catalysis Letters
- Vol. 148 (10) , 3236-3247
Determination of Activation Energy and Ping-Pong Kinetic Model Constants of Enzyme-Catalyzed Self-Epoxidation of Free Fatty Acids using Micro-reactor
- 6 August 2018
- Published by Springer Nature in Catalysis Letters
- Vol. 148 (10) , 3236-3247
Determination of Activation Energy and Ping-Pong Kinetic Model Constants of Enzyme-Catalyzed Self-Epoxidation of Free Fatty Acids using Micro-reactor